Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice. Wu K, Choi A, Koch M, Elbashir S, et al. Vaccine 2021 Nov 8. pii: S0264-410X(21)01435.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu K, Choi A, Koch M, Elbashir S, et al. Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice. Vaccine 2021 Nov 8. pii: S0264-410X(21)01435.
PMID: 34815117